Membership

RFP, CGN and CGA Opportunities

The Alliance is a community dedicated to connecting healthcare education professionals to promote best practices that improve patient care. To help achieve this, we collect information on research proposals and grants offered through other healthcare-related organizations. If your company is interested in posting a request for grant applications, please contact the Alliance Business Office at acehp@acehp.org


Amicus Therapeutics

Amicus Therapeutics is committed to supporting high quality independent medical education (IME) that narrows unmet educational needs and improves healthcare provider knowledge, competence and performance. IME supported by Amicus is intended to ultimately improve the outcomes of patients with rare and orphan diseases.

Amicus is posting a Request for Education (RFE) to inform qualified medical education providers that we are currently accepting requests for the following:

Therapeutic Area: Fabry disease

Program Type: Satellite Symposium and Online Enduring Component at WORLDSymposium 2020

View Request for Education

Submission Deadline: October 18, 2019

Please visit our website at Amicus Global Medical Affairs to learn more details.


Bristol-Myers Squibb

Bristol-Myers Squibb accepts funding requests within the following therapeutic areas of interest. As areas of interest and funding consideration may change periodically, please consult this website frequently. Please note that international funding opportunities may differ.

  • Cardiovascular
  • Immunoscience
  • Oncology
  • Virology
  • Genetically Defined / Rare Diseases

View Request for Proposals / for Education


Genentech

Genentech is seeking to support learning initiatives that demonstrate a strategy that evolves knowledge-based medical education into a “healthcare Improvement” initiative that accelerates the awareness and application of evidence-based medicine, resulting in appropriate care for patients and relevant, measurable, clinical outcomes.

Therapeutic area(s) of interest:

  • Non-Malignant Blood Disorders

View Request for Proposal


Indivior

Indivior supports independent medical education activities that provide for an increased understanding of scientific, clinical, or healthcare issues related to the company’s therapeutic areas of interest. 

Therapeutic areas of interest:

  • Opioid Use Disorder
  • Schizophrenia

To view open RFPs and complete details regarding grant submission, please visit the following site on a regular basis: grants.indivior.com


Medicare Access and CHIP Reauthorization Act of 2015 (MACRA)

The Centers for Medicare & Medicaid Services (CMS) recognizes the benefits of measure development by external stakeholders with specific knowledge of clinician and patient perspectives and needs, such as clinical specialty societies, clinical professional organizations, patient advocacy organizations, educational institutions, independent research organizations, health systems, and other entities. 

On March 2, 2018, CMS published the “Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program” on Grants.gov. The purpose of this Funding Opportunity is to provide technical and funding assistance in the form of cooperative agreements to entities to develop, improve, update, or expand quality measures for use in the Quality Payment Program (QPP). 

For more information and to see the ‘Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Funding Opportunity: Measure Development for the Quality Payment Program’ search by the title or the Catalog of Federal Domestic Assistance (CFDA) number, 93.986 on Grants.gov.


Novo Nordisk Inc.

Novo Nordisk is committed to supporting independent medical education programs that meet the educational needs of health care professionals (HCPs), patients and the community in ways that measurably grow their knowledge and skills to optimize patient or self care in the following therapeutic areas of interest:

  • Diabetes
  • Obesity

Please visit www.novonordiskgrants.com to apply for educational grants and access the IME Funding Document that provides information about educational priorities and available funding as well as current Request for Proposals (RFPs)/Call for Concept Proposals (CCPs) within these therapeutic areas.


Pfizer Independent Grants for Learning & Change (IGLC)

The mission of Pfizer Independent Grants for Learning & Change is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. The Joint Commission is an independent, not-for-profit organization that accredits and certifies nearly 21,000 health care organizations and programs in the United States. 

To view open RFPs and complete details, please visit this webpage.


Sanofi

View the Global Multiple Myeloma RFP. Please review and return your completed proposal via the Sanofi U.S. Grant Website by 5 p.m. EST on Tuesday, October 22, 2019. If a submission is not completed by this date, your proposal will not be accepted.

When entering proposal into the website, please reference the following:

Therapeutic Area:      Oncology
Area of Interest:        Multiple Myeloma
RFP Name:                 GL MM RFP – 10/19

Submission instructions are available on the website. If you have a content question, please contact Malika Wicks at Malika.Wicks@sanofi.com.

View the Non-Physicians Healthcare Providers (HCAS) RFP. Please review and return your completed proposal via the Sanofi U.S. Grant Website by 5 p.m. EST on Monday, October 28, 2019. If a submission is not completed by this date, your proposal will not be accepted. 

When entering proposal into the website, please reference the following:

Therapeutic Area:     Genetic Disease
Area of Interest:        Lysosomal Storage Diseases
RFP Name:                 LSD HCA Education RFP 2019

Please note that you must answer the question, “Are you responding to an RFP?” and select “LSD HCA Education RFP 2019” from the RFP drop-down panel within the grant portal upon submitting your application for this RFP.


Shionogi Inc.

Shionogi accepts funding requests within the following therapeutic areas of interest.

  • Gram-negative multidrug-resistant infectious disease (ID)
  • Thrombocytopenia associated with chronic liver disease (CLD)
  • Opioid-induced Constipation (OIC)

The call for grants (CFG) opportunities will change on a quarterly basis.  Please consult our website to identify current opportunities.


UCB, Inc.

UCB, Inc., is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

6CB, Inc Medical Educational Grants, Medical Affairs, Request for Proposal (RFP): Psoriasis Educational Article

Click here to review the RFP. For complete details, please visit our website.

Proposal Deadline:  9/24/19

Anticipated Proposal Notification Date:  10/25/19